Physician
Children's Urgent Care, LLC
Children's Urgent Care, LLC was paid $16.23M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoCHILDREN'S URGENT CARE, LLC
BIRMINGHAM, AL 35242
BIRMINGHAM, AL 35242
33aNPI1124541438assigned 07/18/2017
33bProvider typePediatrics Physician
28Total paid$16.23M
24GClaims486,776
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Alabama
Rank by total paid#12 of 199
Median peer was paid$702K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,712 | $203K | |
| 2019 | 19,351 | $647K | |
| 2020 | 39,188 | $1.34M | |
| 2021 | 91,265 | $3.12M | |
| 2022 | 144,697 | $4.70M | |
| 2023 | 108,347 | $3.80M | |
| 2024incomplete | 79,216 | $2.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 78,043 | 70,178 | $4.78M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 27% | 53,038 | 46,178 | $4.40M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 38,985 | 35,636 | $1.70M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.9% | 22,225 | 19,511 | $1.28M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.8% | 50,620 | 42,924 | $1.10M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.3% | 109,759 | 50,196 | $1.02M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 4.7% | 29,570 | 28,152 | $756K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.7% | 54,052 | 48,631 | $602K |
| 99051 | 1.2% | 15,001 | 14,068 | $197K | |
| 87807 | <1% | 16,945 | 15,238 | $159K | |
| 87428 | <1% | 2,518 | 1,948 | $81K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 496 | 435 | $36K |
24 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,062 | $23K |
| 99205 | Prolong outpt/office vis | <1% | 156 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 545 | $17K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,215 | $16K |
| 99000 | <1% | 6,825 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 258 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 558 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 174 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 202 | $2K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 444 | $2K |
| 81003 | <1% | 724 | $1K | |
| 81002 | <1% | 365 | $930.35 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 115 | $609.69 |
| 0071A | <1% | 35 | $511.59 | |
| 0072A | <1% | 17 | $463.56 | |
| 73610 | <1% | 16 | $462.20 | |
| 73630 | <1% | 12 | $411.24 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 25 | $403.80 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $263.13 |
| 86308 | <1% | 32 | $150.00 | |
| S8431 | Compression bandage, roll | <1% | 12 | $116.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 78 | $29.06 |
| 94761 | 0% | 627 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARORA, ALLURY (CEO/CMO)
| Provider | Location | Paid |
|---|---|---|
| Urgent Care for Children, PLLC | Hixson, TN | $1.56M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.